Moxumbic
Regenxbio (Nasdak:RGNXSolid biological sciences (Nasdak:SldbDivorced fortunes on Tuesday witnessed after Sarepta Therapeutics (Nasdak:SRPTDisclosure of deaths associated with her genetic treatment product, targeted in Duchene muscle atrophy (DMD).
The genetic treatment associated with the virus (AAV) depends on the genes that SAREPTA is marketing (
https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1363546516/image_1363546516.jpg?io=getty-c-w750
Source link